Skip to main content
. 2020 Jul 1;21(13):4702. doi: 10.3390/ijms21134702

Table 1.

Significant CpG sites that were mapped to genes implicated in IL-1β production or gouty inflammation.

CpG Site Δβ a P Chr Position b Gene c Genomic Features Genetic and meQTL d CIT e Reference f
Implicated in IL-1β Production in Macrophages
cg26201826 1.15% 7.27 × 10−6 5 114598579 PGGT1B TSS200 Y - ↓[10]
cg20419410 0.39% 1.48 × 10−7 7 155089803 INSIG1 5′UTR Y - ↓[11]
cg17618153 −1.38% 1.36 × 10−5 9 129874991 ANGPTL2 5′UTR Y - ↑[12]
cg15686135 −1.24% 1.32 × 10−9 10 49542423 JNK1 (MAPK8) [13] 5′UTR Y - ↑[14]
Expressed in Macrophages and Implicated in IL-1β Production
cg14167017 0.38% 2.78 × 10−7 9 34178925 UBAP1 TSS200 N Y ↓Table S6 of [15,16]
cg03081134 0.49% 8.77 × 10−6 9 36036806 RECK TSS200 N N ↓[17,18]
cg01680773 0.67% 1.13 × 10−5 14 74960124 NPC2 TSS200 N N ↓[19,20]
cg11988568 1.04% 7.84 × 10−7 17 78518917 RAPTOR (RPTOR) [21] 5′UTR N Y ↓[21,22]
Implicated in Gouty Inflammation
cg16745952 0.96% 1.22 × 10−5 11 98891665 CNTN5 TSS200 Y - [6]

Chr: chromosome. a Methylation levels of gout minus methylation levels of non-gout estimated with linear regression, after adjusting for sex, age, smoking history (total pack-years), smoking status, alcohol consumption, and cell subsets. b Positions of the CpG sites in hg19. c Gene names and their alias. d Y denotes CpG sites surviving genetic and meQTL analysis (without genetic variants concomitantly associated with CpG methylation and gout). N denotes CpG sites failing genetic and meQTL analysis (with genetic variants concomitantly associated with CpG methylation and gout). e Y denotes CpG sites passing causal inference tests (CITs), N denotes CpG sites not passing CITs. f References supporting the role of mapped genes in IL-1β production/macrophage expression/gouty inflammation, and ↑ means the gene increases IL-1β production while ↓ means the gene decreases IL-1β production.